Sequana Medical N.V.
Develops implantable medical devices for treating drug-resistant fluid overload.
SEQUA | BR
Overview
Corporate Details
- ISIN(s):
- BE0974340722
- LEI:
- 8755009AN12Y4PEOII07
- Country:
- Belgium
- Address:
- Kortrijksesteenweg 1112 B 102, 9051 Gent
- Website:
- https://www.sequanamedical.com/
- Sector:
- Manufacturing
Description
Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-23 18:30 |
PR Kreos Amendment (ENG) (23 December 2025).pdf
|
English | 303.2 KB | ||
| 2025-12-23 18:30 |
PR Kreos Amendment (NL) (23 december 2025).pdf
|
Dutch | 334.1 KB | ||
| 2025-12-22 18:00 |
6th GEM Capital Increase -- Closing PR (ENG) (22 December 2025).pdf
|
English | 277.0 KB | ||
| 2025-12-22 18:00 |
6th GEM Capital Increase -- Closing PR (NL) (22 December 2025).pdf
|
Dutch | 293.4 KB | ||
| 2025-11-24 18:30 |
2025-11-13 Transparency Notification BlackRock.pdf
|
English | 284.9 KB | ||
| 2025-11-24 18:30 |
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (24 November 20…
|
English | 296.1 KB | ||
| 2025-11-24 18:30 |
Sequana Medical -- Transparency Notification PR BlackRock (NL) (24 November 202…
|
Dutch | 311.7 KB | ||
| 2025-11-14 18:00 |
Sequana Medical -- Fifth GEM Subscription -- Closing PR (ENG) 14 November 2025.…
|
English | 276.3 KB | ||
| 2025-11-14 18:00 |
Sequana Medical -- Fifth GEM Subscription -- Closing PR (NL) 14 November 2025.p…
|
Dutch | 289.5 KB | ||
| 2025-08-14 18:00 |
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (14 August 2025…
|
English | 289.7 KB | ||
| 2025-08-14 18:00 |
Sequana Medical -- Transparency Notification PR BlackRock (NL) (14 August 2025)…
|
Dutch | 317.1 KB | ||
| 2025-08-07 18:00 |
20250807 Sequana Medical - GEM Subscription Notice PR (ENG).pdf
|
English | 232.0 KB | ||
| 2025-08-07 18:00 |
20250807 Sequana Medical - GEM Subscription Notice PR (NL).pdf
|
Dutch | 252.2 KB | ||
| 2025-07-28 18:00 |
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (28 July 2025).…
|
English | 287.8 KB | ||
| 2025-07-28 18:00 |
Sequana Medical -- Transparency Notification PR BlackRock (NL) (28 July 2025).p…
|
Dutch | 314.8 KB |
Automate Your Workflow. Get a real-time feed of all Sequana Medical N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sequana Medical N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sequana Medical N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-06-04 | Fin-2K BV | Executive member | Buy | 16,000 | N/A |
| 2021-05-27 | Crosbie Ian | Board | Buy | 32,000 | N/A |
| 2020-09-07 | Fin-2K BV | Executive member | Buy | 20,036 | N/A |
| 2020-09-04 | Crosbie Ian | Board | Buy | 40,073 | N/A |
| 2019-06-06 | wim ottevaere | Board | Buy | 4,000 | 25,600.00 EUR |
| 2019-03-29 | Fin-2K BV | Executive member | Buy | 20,383 | N/A |
| 2019-03-06 | Crosbie Ian | Board | Buy | 40,766 | N/A |
| 2019-02-26 | Chauvineau Pierre | Board | Buy | 10,192 | N/A |
| 2019-02-13 | wim ottevaere | Board | Buy | 7,000 | 49,345.10 EUR |
Peer Companies
